Endo International plc: Endo to Cease Production and Sale of Qwo (collagenase clostridium histolyticum-aaes)

DUBLIN, Dec. 6, 2022 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that it will cease the production and sale of Endo Aesthetics' Qwo (collagenase clostridium histolyticum-aaes)

Related Keywords

New York ,United States ,Canada ,Dublin ,Ireland ,Canadian ,Blaise Coleman ,Prnewswire Endo International ,Exchange Commission ,Copies Of The Company ,Linkedin ,Company Investor Relations Department ,United States Bankruptcy Court ,Endo Aesthetic ,Endo Aesthetics ,Southern District ,Full Prescribing Information ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Investor Relations Department ,Kendo ,Nternational ,Release ,Production ,Sale ,Collagenase ,Clostridium ,Istolyticum ,Aes ,